Indena is the world’s leading company in the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and personal care industries.Indena, a privately owned Italian company, has around 800 employees (10% of them dedicated to full-time research) and has cultivation, manufacturing, and sales in more than 70 countries throughout the world.

HDL Therapeutics have developed the first therapy of its kind to rapidly reverse coronary atherosclerosis in patients with Homozygous Familial Hypercholesterolemia (HoFH).

Nielsen BioSciences, Inc. is a private, San Diego-based biotechnology company focused on offering medical professionals trusted and valued biological products with wide-ranging applications of cell-mediated immune responses. They are building on a solid foundation of over 40 years developing and delivering antigen-based products.

Beijing Ande Medical Intelligence Technology Co., Ltd. is a Chinese private company located in Beijing. The firm provides event management services. It was founded in 2018. Wei Qun Mo is currently the CEO of the company.

SANUM-Kehlbeck GmbH & Co. KG is a German private company located in Hoya that produces pharmaceutical products. It was founded in 1975 by Heinrich Kehlbeck. Reiner Kehlbeck and Heinfried Kehlbeck are the current co-CEOs of the firm.\nThe company says this about itself: SANUM-Kehlbeck GmbH & Co. KG is a medium sized, family-run, internationally operating pharmaceutical company based in Lower Saxony, with a naturopathically oriented remedy portfolio. SANUM-Kehlbeck GmbH & Co. KG is the sole manufacturer of very special pharmaceuticals in Germany and markets them in many countries around the world.

Pervasis Therapeutics is a clinical stage company developing a broad portfolio of biologically active therapeutics. Building on its deep understanding of the specialized role that the endothelium plays in regulating natural healing and repair processes associated with disease, Pervasis is advancing groundbreaking new therapies to dramatically improve the outcomes of common vascular interventions, such as arteriovenous access, angioplasties, stents, and peripheral and coronary bypass grafts – the failure of which result in serious complications and a significant increase in medical costs.

Nordic Bioscience is a biotech firm that studies extracellular matrix (ECM). It uses Protein Fingerprint technology to identify ECM fragments released from affected tissues and to develop blood-based biomarker assays to quantify disease activity in the pursuit of precision medicine. Nordic Bioscience is based in Herlev, Denmark, and operates a high-quality standard laboratory that conducts clinical trials in accordance with Good Clinical Laboratory Practice (GCLP) and is accredited by the College of American Pathologists (CAP), and has an ISO9001 certificate.

Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France.

Zhongan Information Technology Services Co., Ltd., a subsidiary of ZhongAn Online P&C Insurance Co., Ltd., is a Chinese company that provides information technology services.

Beijing Honghai Technology Development Co., Ltd., established on 2015-09-11, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Sell ​​metal materials,building materials,Equipment;Commissioned production and processing of medical devices;Import and export;Technology Import and Export;Agent import and export;Engaged in the production and development of interventional medical devices and oral medical materials.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Pulse Medical Imaging Technology Shanghai Co. Ltd. is a Chinese company specializing in commercial physical and biological research.

Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden.

Research Development Foundation is an American private company that operates as noncommercial research organizations.

Part of Endo International Plc, Advance Biofactures Corp. is a company headquartered in the United States focused on pharmaceutical preparations.

Advanced BioHealing is an industry leader in the science of regenerative medicine. The Company is focused on the commercialization of cell-based and tissue-engineered products. It currently markets the FDA-approved product Dermagraft®, for diabetic foot ulcers. Additionally, the Company's development pipeline includes a next-generation bioengineered tissue product which is in clinical trials. ABH is a privately held company with research & development offices in New York, NY and manufacturing operations in La Jolla, CA.

Pie Medical Imaging BV, part of Esaote SpA, is a company headquartered in the Netherlands that develops medical imaging software solutions.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.